61 / 100

Prof. Mei luo | Organic and organometallic chemistry | Best Researcher Award

Professor at Hefei university of technology, China 

Dr. Mei Luo is currently serving as an Associate Professor at Hefei University of Technology, bringing a wealth of experience in organic and organometallic chemistry. She obtained her Ph.D. from the University of Science and Technology of China and pursued postdoctoral research at prestigious institutions such as Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. With a strong focus on synthesizing chiral organometallic complexes and drug synthesis, Dr. Luo has contributed significantly to the field through innovative research and academic endeavors.

Author Metrics

Scopus Profile

ORCID Profile

Dr. Mei Luo has achieved notable recognition in academia, boasting over 200 patents since 2006. Her research has been extensively published in reputable journals, highlighting her impact in the areas of metal complex synthesis, characterization, and their applications in medicinal chemistry and catalysis. Her publications reflect a strong interdisciplinary approach, integrating theoretical and experimental methodologies to advance the understanding and application of organometallic chemistry.

Dr. Mei Luo, currently affiliated with Hefei University of Technology in Hefei, China, has a notable academic profile. According to Scopus Author Identifier, her research has garnered 248 citations from 224 documents, with an h-index of 9. She has authored 62 documents indexed in Scopus, reflecting her significant contributions to the field of organic and organometallic chemistry. For more detailed metrics and information, accessing her full profile via Scopus or ORCID would provide comprehensive insights into her research impact and academic achievements.

Education

Dr. Luo earned her M.S. in Chemistry from Hefei University of Technology and completed her Ph.D. at the University of Science and Technology of China. Her academic journey also includes postdoctoral fellowships at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill, where she further honed her expertise in organic and organometallic chemistry.

Research Focus

Dr. Mei Luo’s research primarily revolves around the synthesis of chiral organometallic complexes and drug synthesis. She has made significant contributions to understanding the structural and functional properties of metal complexes, particularly their applications in medicinal chemistry, catalysis, and molecular docking studies.

Professional Journey

Beginning with her educational background, Dr. Luo’s professional journey spans multiple prestigious institutions and positions. After completing her Ph.D., she conducted postdoctoral research at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. Currently, she serves as an Associate Professor at Hefei University of Technology, where she continues to lead research and mentor students in organic and organometallic chemistry.

Honors & Awards

Dr. Mei Luo has received recognition for her contributions to organic and organometallic chemistry, although specific awards and honors were not detailed in the provided information. Her extensive publication record and patent portfolio underscore her achievements and impact within her field of expertise.

Publications Noted & Contributions

Dr. Luo has authored numerous influential publications, focusing on metal complexes with biological applications. Notable publications include studies on the synthesis, characterization, and biological activities of Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands, as well as their antitumor effects. Her research contributions extend to structural investigations, Hirshfeld surface analyses, and quantum mechanical studies of various organometallic compounds.

Mei Luo has authored several notable books and publications, including:

Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands: synthesis, characterization, and anticancer activities

  • Journal: Journal of the Iranian Chemical Society
  • Date: 2024-06
  • DOI: 10.1007/s13738-024-03021-x
  • Contributors: Amir Nazeer, Qasim Umar, Yanting Yang, Mei Luo

A Brief Review: Advancement in the Synthesis of Amine through the Leuckart Reaction

Synthesis, characterization and anticancer activities of Zn2+, Cu2+, Co2+ and Ni2+ complexes involving chiral amino alcohols

  • Journal: RSC Advances
  • Date: 2022
  • DOI: 10.1039/D2RA05576G
  • Contributors: Qasim Umar, Y. H. Huang, Amir Nazeer, Hao Yin, Jing Cheng Zhang, Mei Luo, X. G. Meng

Correction to: One-step templated synthesis of chiral organometallic salicyloxazoline complexes

  • Journal: BMC Chemistry
  • Date: 2019-05-10
  • DOI: 10.1186/s13065-019-0577-8
  • Contributors: Mei Luo, Jing Cheng Zhang, Hao Yin, Cheng Ming Wang, Susan Morris-Natschke, Kuo-Hsiung Lee

One-step templated synthesis of chiral organometallic salicyloxazoline complexes

  • Journal: BMC Chemistry
  • Date: 2019-04-04
  • DOI: 10.1186/s13065-019-0565-z
  • Contributors: Mei Luo, Jing Cheng Zhang, Hao Yin, Cheng Ming Wang, Susan Morris-Natschke, Kuo-Hsiung Le

Research Timeline

Dr. Mei Luo’s research journey began with her doctoral studies at the University of Science and Technology of China, followed by postdoctoral research positions at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. Since joining Hefei University of Technology as an Associate Professor, she has continued to expand her research focus on chiral organometallic complex synthesis and drug synthesis, publishing extensively in respected scientific journals.

2024:

  1. Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands: synthesis, characterization, and anticancer activities
    • This study focused on synthesizing and characterizing metal complexes with aza-heterocyclic ligands. It explored their potential anticancer activities, contributing to the field of medicinal chemistry and organometallic complexes.

2023:

  1. 一Research progress on one-pot synthesis of oxazoline metal complexes
    • This publication (translated as “Progress in One-Pot Synthesis of Oxazoline Metal Complexes”) discussed advancements in the one-pot synthesis method for creating oxazoline metal complexes, emphasizing efficiency and innovation in synthetic organic chemistry.
  2. Combining Effect of Zn2+, Cu2+, Co2+, and Ni2+ Complexes Containing Chiral Amino Alcohols: Synthesis, Characterization and their Anticancer Activities
    • This research delved into the synthesis and characterization of metal complexes containing chiral amino alcohols. It investigated their combined effects and anticancer activities, contributing valuable insights into the potential therapeutic applications of these complexes.

These recent achievements highlight Mei Luo’s ongoing contributions to the fields of organic synthesis, organometallic chemistry, and medicinal chemistry, particularly focusing on innovative synthesis methods and the development of compounds with significant biological activities.

Collaborations and Projects

Dr. Luo actively collaborates with researchers both nationally and internationally, enhancing her research impact and fostering interdisciplinary approaches in organic and organometallic chemistry. Her collaborations encompass projects that explore novel synthesis methodologies, structural characterization techniques, and the biological applications of metal complexes, contributing to advancements in medicinal chemistry and catalysis.

Mei luo | Organic and organometallic chemistry | Best Researcher Award

You May Also Like